Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meyling H Cheok

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Pharmacogenomics|November 7, 2009
Pharmacogenomics in acute myeloid leukemiaChristophe Roumier, Meyling H Cheok
Oncotarget|March 22, 2018
Impact of CNA on AML prognosisFanny Gonzales, Meyling H Cheok
Nature Reviews. Cancer|February 24, 2006
Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapyMeyling H Cheok, William E Evans
Pharmacogenomics|November 23, 2012
Pharmacogenomic considerations of xenograft mouse models of acute leukemiaSoizic Guihard, Pauline Peyrouze, Meyling H Cheok
Annual Review of Pharmacology and Toxicology|January 13, 2006
Pharmacogenomics of acute leukemiaMeyling H Cheok, Sanne Lugthart, William E Evans
Journal of Pediatric Hematology/Oncology|March 6, 2009
High-dose methotrexate: the rationaleMeyling H Cheok, William E Evans, Leo Kager
Seminars in Hematology|December 23, 2008
Pharmacogenetics in acute lymphoblastic leukemiaMeyling H Cheok, Nicolas Pottier, Leo Kager, et al.
Expert Opinion on Therapeutic Targets|April 28, 2021
Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implicationsFanny Gonzales, Adeline Barthélémy, Pauline Peyrouze, et al.
Pediatric Blood & Cancer|March 30, 2022
Ex vivo drug sensitivity profiling-guided treatment of a relapsed pediatric mixed-phenotype acute leukemia with venetoclax and azacitidineFanny Gonzales, Audrey Guilmatre, Adeline Barthélémy, et al.
Nature Genetics|April 22, 2003
Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cellsMeyling H Cheok, Wenjian Yang, Ching-Hon Pui, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Pharmacogenomics|November 7, 2009
Pharmacogenomics in acute myeloid leukemiaChristophe Roumier, Meyling H Cheok
Oncotarget|March 22, 2018
Impact of CNA on AML prognosisFanny Gonzales, Meyling H Cheok
Nature Reviews. Cancer|February 24, 2006
Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapyMeyling H Cheok, William E Evans
Pharmacogenomics|November 23, 2012
Pharmacogenomic considerations of xenograft mouse models of acute leukemiaSoizic Guihard, Pauline Peyrouze, Meyling H Cheok
Annual Review of Pharmacology and Toxicology|January 13, 2006
Pharmacogenomics of acute leukemiaMeyling H Cheok, Sanne Lugthart, William E Evans
Journal of Pediatric Hematology/Oncology|March 6, 2009
High-dose methotrexate: the rationaleMeyling H Cheok, William E Evans, Leo Kager
Seminars in Hematology|December 23, 2008
Pharmacogenetics in acute lymphoblastic leukemiaMeyling H Cheok, Nicolas Pottier, Leo Kager, et al.
Expert Opinion on Therapeutic Targets|April 28, 2021
Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implicationsFanny Gonzales, Adeline Barthélémy, Pauline Peyrouze, et al.
Pediatric Blood & Cancer|March 30, 2022
Ex vivo drug sensitivity profiling-guided treatment of a relapsed pediatric mixed-phenotype acute leukemia with venetoclax and azacitidineFanny Gonzales, Audrey Guilmatre, Adeline Barthélémy, et al.
Nature Genetics|April 22, 2003
Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cellsMeyling H Cheok, Wenjian Yang, Ching-Hon Pui, et al.
Pageof 3